• Oral CXCR4 Antagonist Mavorixafor: Phase 3 Outcomes in WHIM

  2026-05-09

  A pivotal phase 3 trial demonstrated that oral CXCR4 antagonist mavorixafor significantly improves neutrophil and lymphocyte counts and reduces infection rates in WHIM syndrome patients. This study marks a major advance in addressing the molecular root of this rare immunodeficiency and sets a new benchmark for targeted therapy in rare hematologic disorders.

• Extracellular Vesicle-Driven Protein Degradation via Autopha

  2026-05-08

  This study introduces an extracellular vesicle-based targeted protein degradation (EVTPD) platform that harnesses autophagy for the selective removal of extracellular proteins. The work clarifies the vesicular degradation pathway and demonstrates multi-targeted anti-inflammatory efficacy, laying the foundation for advanced therapeutic and research applications.

• Methotrexate as a Folate Antagonist: Optimizing Lab Workflow

  2026-05-07

  Methotrexate’s dual role as a folate antagonist and immunosuppressive agent enables robust, reproducible research into apoptosis and anti-inflammatory mechanisms. This article translates new advances in biomimetic permeability modeling and validated methotrexate protocols into actionable guidance for experimental setup, troubleshooting, and assay optimization.

• O-GlcNAcylation Links Wnt Signaling to Bone Formation via Gl

  2026-05-07

  This study reveals that O-GlcNAcylation is essential for Wnt-driven osteogenesis, acting by reprogramming aerobic glycolysis through PDK1 stabilization in osteoblasts. The findings clarify a key metabolic mechanism underlying bone formation and suggest new avenues for research targeting Wnt signaling in skeletal biology.

• Sulfo-NHS-SS-Biotin Kit: Precision Cell Surface Biotinylatio

  2026-05-06

  The Sulfo-NHS-SS-Biotin Kit empowers researchers to achieve reversible, water-soluble biotinylation of cell surface proteins—crucial for dynamic interactome mapping and advanced affinity workflows. Its unique chemistry and workflow enhancements unlock new insights into glycoRNA–protein domains and selective membrane labeling.

• SC 79: Advancing Cytosolic Akt Activation for Stroke Researc

  2026-05-06

  Explore how SC 79, a potent Akt activator, uniquely enables cytosolic Akt pathway modulation for neuroprotection in ischemic stroke. This article delivers deep scientific insight and practical assay guidance beyond existing reviews.

• AIBP-LRP2–HDL Axis Restricts CXCR4+ Capillary Expansion in I

  2026-05-05

  This study uncovers a two-phase mechanism by which AIBP-LRP2–mediated HDL uptake restricts the expansion of CXCR4+ stemlike capillary endothelial cells, impacting collateral vessel formation in ischemic disease. These findings clarify how lipid metabolism and immune responses orchestrate vascular remodeling, suggesting new strategies for therapeutic revascularization.

• ATRX-Deficient Glioma Cells Respond to RTK/PDGFR Inhibition

  2026-05-05

  This study demonstrates that high-grade glioma cells lacking ATRX are significantly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors than their ATRX-proficient counterparts. The findings highlight ATRX status as a critical biomarker for therapeutic response and inform future trial designs and experimental strategies in cancer biology research.

• Ginsenoside Rg1 Restores Neuroimmune Balance After Prolonged

  2026-05-04

  This study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, mitigates neuroimmune disruptions and cognitive deficits induced by prolonged isoflurane anesthesia in mice. The findings highlight Rg1’s role in regulatory T cell-mediated restoration of the gut-immune-brain axis, providing a mechanistic basis for its neuroprotective action.

• CLK4 Regulates Cardiac Hypertrophy via NEXN Phosphorylation

  2026-05-04

  This study identifies CDC-like kinase 4 (CLK4) as a pivotal regulator of pathological cardiac hypertrophy through its direct phosphorylation of nexilin (NEXN). The findings highlight a mechanistic link between CLK4 deficiency, altered protein phosphorylation signaling, and the development of heart failure, offering potential new therapeutic targets for cardiovascular disease.

• Sulfo-NHS-SS-Biotin: Advanced Cell Surface Protein Labeling

  2026-05-03

  The Sulfo-NHS-SS-Biotin Kit empowers precise, reversible biotinylation of cell surface proteins and antibodies, leveraging unique water solubility and disulfide-cleavable linkers for advanced workflows. Its design enables selective, artifact-free labeling and robust purification, making it a cornerstone for modern interactome mapping and surface proteomics.

• Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular

  2026-05-02

  Metoprolol Tartrate stands apart as a β1-adrenergic blocking agent with proven selectivity, enabling cardiovascular and hematopoietic research without off-target β2/β3 effects. This article translates recent comparative findings and experimental best practices into practical protocols, troubleshooting tips, and strategic workflow enhancements for in vitro and in vivo applications.

• Dihydrotestosterone: Applied Workflows & Resistance Research

  2026-05-02

  Dihydrotestosterone (DHT) empowers researchers to dissect androgen receptor and EGFR/ERBB2 pathways in cancer and neurodegeneration. This guide details advanced workflows, troubleshooting strategies, and the practical impact of recent discoveries on therapy resistance.

• Mavorixafor Hydrochloride: Redefining CXCR4 Antagonist Utili

  2026-05-01

  Discover how Mavorixafor hydrochloride sets a new benchmark as a CXCR4 antagonist for translational research. This article unpacks unique mechanistic insights and assay guidance beyond current literature.

• Cy7 NHS Ester (A8109): Technical Guidance for Protein Labeli

  2026-04-30

  Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye for rapid, site-specific labeling of amino groups in proteins and peptides without the need for organic solvents. Its design minimizes quenching and denaturation, making it suitable for in vivo and live-cell fluorescent imaging. However, it should not be used for targets lacking accessible amines or for protocols requiring long-term storage of dye solutions.

16604 records 1/1107 page Next 12345 下5页 Last page